Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-09 Purchase |
2023-11-09 4:35 pm |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
1,560,000 | $9 | $14,040,000 | 6,922,870 (Indirect) |
View |
| 2023-06-20 Purchase |
2023-06-20 4:30 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
4,760,000 | $22.66 | $107,861,600 | 13,959,973 (Indirect) |
View |
| 2022-12-05 Purchase |
2022-12-07 4:30 pm |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
1,250,000 | $12 | $15,000,000 | 5,362,870 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 4:44 pm |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
1,785,000 | $14 | $24,990,000 | 4,112,870 (Indirect) |
View |
| 2021-03-08 Sale |
2021-03-10 7:45 pm |
Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Matrix Capital Management Company LP See Remarks |
806,000 | $39.99 | $32,228,827 | 12,310,594 (Indirect Direct) |
View |
| 2020-07-20 Sale |
2020-07-22 4:15 pm |
Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Matrix Capital Management Company LP See Remarks 10% Owner |
2,000,000 | $40 | $80,000,000 | 13,115,090 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-01 Conversion |
2024-07-03 4:45 pm |
N/A N/A |
ALUMIS INC. | AyurMaya Capital Management Company LP GOEL DAVID E. See Remarks 10% Owner |
46,228,371 | $0 | 10,645,966 (Indirect) |
View | |
| 2024-07-01 Option Award |
2024-07-03 4:45 pm |
N/A N/A |
ALUMIS INC. | AyurMaya Capital Management Company LP GOEL DAVID E. See Remarks 10% Owner |
2,500,000 | $16 | 10,645,966 (Indirect) |
View | |
Ownership |
2024-06-27 6:42 pm |
N/A N/A |
ALUMIS INC. | AyurMaya Capital Management Company LP GOEL DAVID E. See Remarks 10% Owner |
0 | $0 | 8,145,966 (Indirect) |
View | |
| 2023-05-09 Conversion |
2023-05-11 4:10 pm |
N/A N/A |
ACELYRIN Inc. | SLRN | AyurMaya Capital Management Company LP GOEL DAVID E. See Remarks |
18,669,470 | $0 | 9,334,735 (Indirect) |
View |
Ownership |
2023-05-04 7:00 pm |
N/A N/A |
ACELYRIN Inc. | SLRN | AyurMaya Capital Management Company LP GOEL DAVID E. See Remarks 10% Owner |
0 | $0 | 9,334,735 (Indirect) |
View |
Ownership |
2022-06-03 10:54 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
0 | $0 | 9,199,973 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 4:44 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
2,327,870 | $0 | 4,112,870 (Indirect) |
View |
Ownership |
2021-10-28 8:39 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
0 | $0 | 2,327,870 (Indirect) |
View |
| 2021-02-15 Option Award |
2021-02-17 9:40 pm |
N/A 2031-02-15 |
Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Director |
5,263 | $0 | 5,263 (Direct) |
View |